Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
doi: 10.1038/cdd.2009.107 86 FrancoR.CidlowskiJ
If you miss a scheduled dose, contact your provider for advice
The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years
US$ 21.20
US$ 23.39
US$ 27.48
US$ 29.10
US$ 28.28
US$ 20.50
US$ 27.79
